Oncorus (ONCR) Short Interest Ratio & Short Volume → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free ONCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial Media Oncorus Short Interest DataCurrent Short Volume1,080,000 sharesPrevious Short Volume447,700 sharesChange Vs. Previous Month+141.23%Dollar Volume Sold Short$83,808.00Short Interest Ratio / Days to Cover0.2Last Record DateJune 15, 2023Outstanding Shares26,090,000 sharesFloat Size16,680,000 sharesShort Percent of Float6.47%Today's Trading Volume135,900 sharesAverage Trading Volume1,333,593 sharesToday's Volume Vs. Average10% Short Selling Oncorus ? Sign up to receive the latest short interest report for Oncorus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatONCR Short Interest Over TimeONCR Days to Cover Over TimeONCR Percentage of Float Shorted Over Time Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Oncorus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20231,080,000 shares $83,808.00 +141.2%6.5%0.2 $0.08 5/31/2023447,700 shares $90,211.55 +181.8%2.7%0.5 $0.20 5/15/2023158,900 shares $48,941.20 -3.4%1.0%1.9 $0.31 4/30/2023164,400 shares $54,252.00 -7.9%1.0%1.8 $0.33 4/15/2023178,400 shares $53,698.40 -6.5%1.1%1.1 $0.30 3/31/2023190,800 shares $65,654.28 -28.1%1.1%0.6 $0.34 Get the Latest News and Ratings for ONCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncorus and its competitors with MarketBeat's FREE daily newsletter. 3/15/2023265,300 shares $88,079.60 -3.2%1.6%0.8 $0.33 2/28/2023274,000 shares $109,600.00 +0.7%1.6%0.8 $0.40 2/15/2023272,000 shares $104,774.40 -74.8%1.6%0.8 $0.39 1/31/20231,080,000 shares $480,492.00 +14.8%6.5%3.3 $0.44 1/15/2023940,400 shares $338,544.00 +5.6%5.3%3.6 $0.36 12/30/2022890,400 shares $225,538.32 +3.9%5.0%7.5 $0.25 12/15/2022857,200 shares $317,164.00 -1.6%4.8%9.3 $0.37 11/30/2022871,300 shares $418,311.13 +2.2%4.9%9.5 $0.48 11/15/2022852,400 shares $447,510.00 +20.7%4.8%11.1 $0.53 10/31/2022706,200 shares $536,712.00 +46.8%4.0%10.3 $0.76 10/15/2022481,100 shares $390,989.97 -7.3%3.0%7 $0.81 9/30/2022519,100 shares $441,235.00 +21.4%3.2%8.4 $0.85 9/15/2022427,600 shares $491,740.00 +6.4%2.7%4.3 $1.15 8/31/2022401,900 shares $522,470.00 +0.5%2.5%3.3 $1.30 8/15/2022399,800 shares $659,670.00 -0.5%2.5%2.1 $1.65 7/31/2022401,900 shares $522,470.00 -1.1%2.5%2 $1.30 7/15/2022406,400 shares $532,384.00 -5.2%2.5%2 $1.31 6/30/2022428,800 shares $540,288.00 -64.0%2.7%1.9 $1.26 6/15/20221,190,000 shares $1.83 million +8.2%7.4%5 $1.54 5/31/20221,100,000 shares $1.31 million +3.8%6.9%5.7 $1.19 5/15/20221,060,000 shares $1.23 million +2.9%6.6%7.9 $1.16 4/30/20221,030,000 shares $1.21 million +31.9%6.4%7.4 $1.17 4/15/2022780,800 shares $1.16 million -2.6%4.9%5.7 $1.48 3/31/2022801,500 shares $1.43 million +6.2%5.0%6.3 $1.78 3/15/2022755,000 shares $1.09 million +9.9%4.7%6.4 $1.44 2/28/2022686,800 shares $1.45 million +0.4%4.3%5.3 $2.11 2/15/2022683,800 shares $1.93 million +14.0%4.3%5.3 $2.82 1/31/2022599,600 shares $2.08 million +3.7%3.8%2.6 $3.47 1/15/2022578,100 shares $2.45 million -3.7%3.6%2.6 $4.23 12/31/2021600,000 shares $3.16 million +11.7%3.8%2.6 $5.27 12/15/2021537,100 shares $2.79 million +4.0%3.4%2.4 $5.19 11/30/2021516,700 shares $2.86 million -10.1%3.2%2.5 $5.54 11/15/2021574,500 shares $3.32 million -14.2%3.5%2.9 $5.78 10/29/2021669,500 shares $7.14 million +2.3%3.5%7.6 $10.66Putin and other countries have a plan (Ad)Did you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy ONCR Short Interest - Frequently Asked Questions What is Oncorus' current short interest? Short interest is the volume of Oncorus shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 1,080,000 shares of ONCR short. 6.47% of Oncorus' shares are currently sold short. Learn More on Oncorus' current short interest. What is a good short interest percentage for Oncorus? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.47% of Oncorus' floating shares are currently sold short. Is Oncorus' short interest increasing or decreasing? Oncorus saw a increase in short interest in June. As of June 15th, there was short interest totaling 1,080,000 shares, an increase of 141.2% from the previous total of 447,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Oncorus' float size? Oncorus currently has issued a total of 26,090,000 shares. Some of Oncorus' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncorus currently has a public float of 16,680,000 shares. How does Oncorus' short interest compare to its competitors? 6.47% of Oncorus' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Oncorus: GeoVax Labs, Inc. (0.31%), Atreca, Inc. (0.37%), 60 Degrees Pharmaceuticals, Inc. (0.75%), Phio Pharmaceuticals Corp. (0.47%), Aravive, Inc. (1.81%), TransCode Therapeutics, Inc. (0.61%), NexImmune, Inc. (2.26%), Onconetix, Inc. (3.17%), Mustang Bio, Inc. (2.35%), Agile Therapeutics, Inc. (12.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Co. ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks. What does it mean to sell short Oncorus stock? Short selling ONCR is an investing strategy that aims to generate trading profit from Oncorus as its price is falling. ONCR shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncorus? A short squeeze for Oncorus occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONCR, which in turn drives the price of the stock up even further. How often is Oncorus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONCR, twice per month. The most recent reporting period available is June, 15 2023. More Short Interest Resources from MarketBeat Related Companies: GOVX Short Squeeze BCEL Short Squeeze SXTP Short Squeeze PHIO Short Squeeze ARAV Short Squeeze RNAZ Short Squeeze NEXI Short Squeeze ONCO Short Squeeze MBIO Short Squeeze AGRX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ONCR) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders